Anti-SARS-CoV-2 nsp14 Polyklonale Antilichaam

E. coli - derived recombinant SARS-CoV-2 nsp14 (Ala5926-Thr6449) .

2'-O-methyltransferase nsp16, 3C-like proteinase nsp5, 3CL-PRO, 3CLp, EC:2.1.1.56, EC:2.1.1.57, EC:2.7.7.48, EC:2.7.7.50, EC:3.1.13.-, EC:3.4.19.12, EC:3.4.22.-, EC:3.4.22.69, EC:3.6.4.12, EC:3.6.4.13, EC:4.6.1.-, ExoN, GFL, Growth factor-like peptide, Guanine-N7 methyltransferase nsp14, Hel, Helicase nsp13, Host translation inhibitor nsp1, Leader protein, Main protease, Mpro, NendoU, Non-structural protein 1, Non-structural protein 10, Non-structural protein 12, Non-structural protein 13, Non-structural protein 14, Non-structural protein 15, Non-structural protein 16, Non-structural protein 2, Non-structural protein 3, Non-structural protein 4, Non-structural protein 5, Non-structural protein 6, Non-structural protein 7, Non-structural protein 8, Non-structural protein 9, ORF1ab polyprotein, PL-PRO, PL2-PRO, Papain-like protease nsp3, Papain-like proteinase, Pol, Proofreading exoribonuclease nsp14, RNA-capping enzyme subunit nsp9, RNA-directed RNA polymerase nsp12, RdRp, Replicase polyprotein 1ab, SARS coronavirus main proteinase, Uridylate-specific endoribonuclease nsp15, Viral protein genome-linked nsp9, nsp1, nsp10, nsp12, nsp13, nsp14, nsp15, nsp16, nsp2, nsp3, nsp4, nsp5, nsp6, nsp7, nsp8, nsp9, p65 homolog, pp1ab, rep

ELISA, IHC, WB

Purified by antigen affinity column.

Liquid

0.01M PBS, pH 7.4, 50% Glycerol, 0.05% Proclin 300.

ELISA:1:5000-1:20000; IHC:1:50-1:500; WB:1:500-1:2000

For research use only

Bat coronavirus Rp3/2004, Bat coronavirus 279/2005, Bat coronavirus HKU3, Severe acute respiratory syndrome coronavirus 2, Severe acute respiratory syndrome coronavirus

IgG

P0DTD1